1095 related articles for article (PubMed ID: 15353911)
1. Effect of irbesartan on the antioxidant defence system and nitric oxide release in diabetic rat kidney.
Anjaneyulu M; Chopra K
Am J Nephrol; 2004; 24(5):488-96. PubMed ID: 15353911
[TBL] [Abstract][Full Text] [Related]
2. Diltiazem attenuates oxidative stress in diabetic rats.
Anjaneyulu M; Chopra K
Ren Fail; 2005; 27(3):335-44. PubMed ID: 15957552
[TBL] [Abstract][Full Text] [Related]
3. Nordihydroguairetic acid, a lignin, prevents oxidative stress and the development of diabetic nephropathy in rats.
Anjaneyulu M; Chopra K
Pharmacology; 2004 Sep; 72(1):42-50. PubMed ID: 15292654
[TBL] [Abstract][Full Text] [Related]
4. Effect of angiotensin-converting enzyme inhibitor and angiotensin receptor blocker on oxidative stress and metabolism of elements in kidney of STZ-induced diabetic rats.
Pastacı Özsobacı N; Karataş M; Tunçdemir M; Özcelik D
Arch Biochem Biophys; 2024 Jan; 751():109851. PubMed ID: 38065251
[TBL] [Abstract][Full Text] [Related]
5. Irbesartan ameliorates diabetic nephropathy by reducing the expression of connective tissue growth factor and alpha-smooth-muscle actin in the tubulointerstitium of diabetic rats.
Ren X; Guan G; Liu G; Liu G
Pharmacology; 2009; 83(2):80-7. PubMed ID: 19065061
[TBL] [Abstract][Full Text] [Related]
6. Combination therapy with spironolactone and candesartan protects against streptozotocin-induced diabetic nephropathy in rats.
Hofni A; El-Moselhy MA; Taye A; Khalifa MM
Eur J Pharmacol; 2014 Dec; 744():173-82. PubMed ID: 25446917
[TBL] [Abstract][Full Text] [Related]
7. Effect of angiotensin-converting enzyme inhibition and angiotensin II type 1 receptor blockade on streptozotocin-induced diabetic nephropathy.
Sen S; Kanter M; Ustundag S; Aktas C; Dogutan H; Yalcin O
Ren Fail; 2008; 30(10):1023-33. PubMed ID: 19016156
[TBL] [Abstract][Full Text] [Related]
8. Curcumin, the active principle of turmeric (Curcuma longa), ameliorates diabetic nephropathy in rats.
Sharma S; Kulkarni SK; Chopra K
Clin Exp Pharmacol Physiol; 2006 Oct; 33(10):940-5. PubMed ID: 17002671
[TBL] [Abstract][Full Text] [Related]
9. Experimental diabetic nephropathy can be prevented by propolis: Effect on metabolic disturbances and renal oxidative parameters.
Abo-Salem OM; El-Edel RH; Harisa GE; El-Halawany N; Ghonaim MM
Pak J Pharm Sci; 2009 Apr; 22(2):205-10. PubMed ID: 19339234
[TBL] [Abstract][Full Text] [Related]
10. Downregulation of apoptosis and modulation of TGF-β1 by sodium selenate prevents streptozotocin-induced diabetic rat renal impairment.
Roy S; Dontamalla SK; Mondru AK; Sannigrahi S; Veerareddy PR
Biol Trace Elem Res; 2011 Jan; 139(1):55-71. PubMed ID: 20174975
[TBL] [Abstract][Full Text] [Related]
11. [Influence of irbesartan on renal hypertrophy and thickening of glomerular basement-membrane in streptozotocin-induced diabetic rats].
Liu BC; Luo DD; Sun J; Ma KL; Ruan XZ
Zhonghua Nei Ke Za Zhi; 2003 May; 42(5):320-3. PubMed ID: 12882713
[TBL] [Abstract][Full Text] [Related]
12. Attenuation of renoinflammatory cascade in experimental model of diabetic nephropathy by sesamol.
Kuhad A; Sachdeva AK; Chopra K
J Agric Food Chem; 2009 Jul; 57(14):6123-8. PubMed ID: 19601660
[TBL] [Abstract][Full Text] [Related]
13. Renal expression of angiotensin receptors in long-term diabetes and the effects of angiotensin type 1 receptor blockade.
Bonnet F; Candido R; Carey RM; Casley D; Russo LM; Osicka TM; Cooper ME; Cao Z
J Hypertens; 2002 Aug; 20(8):1615-24. PubMed ID: 12172324
[TBL] [Abstract][Full Text] [Related]
14. N-acetylcysteine protects against diabetic nephropathy through control of oxidative and nitrosative stress by recovery of nitric oxide in rats.
Nogueira GB; Punaro GR; Oliveira CS; Maciel FR; Fernandes TO; Lima DY; Rodrigues AM; Mouro MG; Araujo SRR; Higa EMS
Nitric Oxide; 2018 Aug; 78():22-31. PubMed ID: 29778909
[TBL] [Abstract][Full Text] [Related]
15. Amelioration of cyclosporine nephrotoxicity by irbesartan, A selective AT1 receptor antagonist.
Chander V; Singh D; Tirkey N; Chander H; Chopra K
Ren Fail; 2004 Sep; 26(5):467-77. PubMed ID: 15526904
[TBL] [Abstract][Full Text] [Related]
16. Tropisetron ameliorates early diabetic nephropathy in streptozotocin-induced diabetic rats.
Barzegar-Fallah A; Alimoradi H; Asadi F; Dehpour AR; Asgari M; Shafiei M
Clin Exp Pharmacol Physiol; 2015 Apr; 42(4):361-8. PubMed ID: 25676798
[TBL] [Abstract][Full Text] [Related]
17. Renoprotective activity of telmisartan versus pioglitazone on ischemia/reperfusion induced renal damage in diabetic rats.
Tawfik MK
Eur Rev Med Pharmacol Sci; 2012 May; 16(5):600-9. PubMed ID: 22774400
[TBL] [Abstract][Full Text] [Related]
18. BAY 11-7082 ameliorates diabetic nephropathy by attenuating hyperglycemia-mediated oxidative stress and renal inflammation via NF-κB pathway.
Kolati SR; Kasala ER; Bodduluru LN; Mahareddy JR; Uppulapu SK; Gogoi R; Barua CC; Lahkar M
Environ Toxicol Pharmacol; 2015 Mar; 39(2):690-9. PubMed ID: 25704036
[TBL] [Abstract][Full Text] [Related]
19. Melatonin reduces urinary excretion of N-acetyl-beta-D-glucosaminidase, albumin and renal oxidative markers in diabetic rats.
Oktem F; Ozguner F; Yilmaz HR; Uz E; Dündar B
Clin Exp Pharmacol Physiol; 2006; 33(1-2):95-101. PubMed ID: 16445706
[TBL] [Abstract][Full Text] [Related]
20. Renal protection by low dose irbesartan in diabetic nephropathy is paralleled by a reduction of inflammation, not of endoplasmic reticulum stress.
Hartner A; Cordasic N; Klanke B; Menendez-Castro C; Veelken R; Schmieder RE; Hilgers KF
Biochim Biophys Acta; 2014 Apr; 1842(4):558-65. PubMed ID: 24418215
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
